BIOMAT Database Logo BIOMAT Database Logo

Membrane alterations associated with progressive adriamycin resistance. 1982

C Wheeler, and R Rader, and D Kessel

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug

Related Publications

C Wheeler, and R Rader, and D Kessel
Probing membrane alterations associated with anthracycline resistance using fluorescent dyes.
November 1988, Biochemical pharmacology,
C Wheeler, and R Rader, and D Kessel
Membrane alterations associated with hemoglobinopathies.
October 1970, Seminars in hematology,
C Wheeler, and R Rader, and D Kessel
Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones.
May 1988, Antimicrobial agents and chemotherapy,
C Wheeler, and R Rader, and D Kessel
Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content.
January 2012, PloS one,
C Wheeler, and R Rader, and D Kessel
Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes.
January 1990, The Journal of antimicrobial chemotherapy,
C Wheeler, and R Rader, and D Kessel
[Alterations of the erythrocyte membrane in progressive muscular dystrophy].
December 1979, Recenti progressi in medicina,
C Wheeler, and R Rader, and D Kessel
Evaluation of membrane fluidity effects and enzyme activities alterations in adriamycin neurotoxicity.
April 1987, Biochemical pharmacology,
C Wheeler, and R Rader, and D Kessel
Progressive myocardial dysfunction associated with increased vascular resistance.
October 1980, The American journal of physiology,
C Wheeler, and R Rader, and D Kessel
Alterations of membrane fluidity in K562 cells exposed to the anticancer drug adriamycin.
August 1994, Research communications in molecular pathology and pharmacology,
C Wheeler, and R Rader, and D Kessel
Morphological alterations induced by adriamycin.
January 1983, Folia morphologica,
Copied contents to your clipboard!